321 related articles for article (PubMed ID: 26902416)
1. The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer.
Xiao X; Huang X; Ye F; Chen B; Song C; Wen J; Zhang Z; Zheng G; Tang H; Xie X
Sci Rep; 2016 Feb; 6():21735. PubMed ID: 26902416
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of
Zhang Y; Liu G; Gao X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28894025
[TBL] [Abstract][Full Text] [Related]
3. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect.
Li L; Kang L; Zhao W; Feng Y; Liu W; Wang T; Mai H; Huang J; Chen S; Liang Y; Han J; Xu X; Ye Q
Cancer Lett; 2017 Aug; 400():89-98. PubMed ID: 28461244
[TBL] [Abstract][Full Text] [Related]
4. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
[TBL] [Abstract][Full Text] [Related]
5. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
Wang J; Wang H; Liu A; Fang C; Hao J; Wang Z
Oncotarget; 2015 Aug; 6(23):19456-68. PubMed ID: 26062441
[TBL] [Abstract][Full Text] [Related]
6. miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.
Hu S; Jiang Q; Luo D; Zhao L; Fu X; Chen Y; Song X; Li L; Zhao H; He Y; Peng B
Oncotarget; 2016 Jul; 7(30):48423-48431. PubMed ID: 27374173
[TBL] [Abstract][Full Text] [Related]
7. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
8. miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
Hua S; Liu C; Liu L; Wu D
Biochem Biophys Res Commun; 2018 Feb; 496(3):947-954. PubMed ID: 29360449
[TBL] [Abstract][Full Text] [Related]
9. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis.
Chen C; Bai L; Cao F; Wang S; He H; Song M; Chen H; Liu Y; Guo J; Si Q; Pan Y; Zhu R; Chuang TH; Xiang R; Luo Y
Oncogene; 2019 Jun; 38(23):4527-4539. PubMed ID: 30742065
[TBL] [Abstract][Full Text] [Related]
10. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
Zheng XM; Xu CW; Wang F
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
Li X; Zhao H; Zhou X; Song L
Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
[TBL] [Abstract][Full Text] [Related]
12. miR-200c inhibits breast cancer proliferation by targeting KRAS.
Song C; Liu LZ; Pei XQ; Liu X; Yang L; Ye F; Xie X; Chen J; Tang H; Xie X
Oncotarget; 2015 Oct; 6(33):34968-78. PubMed ID: 26392416
[TBL] [Abstract][Full Text] [Related]
13. MiR-34a suppresses osteoblast differentiation through glycolysis inhibition by targeting lactate dehydrogenase-A (LDHA).
Hong M; Zhang XB; Xiang F; Fei X; Ouyang XL; Peng XC
In Vitro Cell Dev Biol Anim; 2020 Jun; 56(6):480-487. PubMed ID: 32719987
[TBL] [Abstract][Full Text] [Related]
14. miR-489 suppresses multiple myeloma cells growth through inhibition of LDHA-mediated aerobic glycolysis.
Wu H; Wang X; Wu T; Yang S
Genes Genomics; 2020 Mar; 42(3):291-297. PubMed ID: 31872383
[TBL] [Abstract][Full Text] [Related]
15. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.
Shao X; Zheng X; Ma D; Liu Y; Liu G
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33645623
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a modulates chemosensitivity of breast cancer cells to adriamycin by targeting Notch1.
Li XJ; Ji MH; Zhong SL; Zha QB; Xu JJ; Zhao JH; Tang JH
Arch Med Res; 2012 Oct; 43(7):514-21. PubMed ID: 23085450
[TBL] [Abstract][Full Text] [Related]
18. High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.
Huang X; Li X; Xie X; Ye F; Chen B; Song C; Tang H; Xie X
Breast; 2016 Dec; 30():39-46. PubMed ID: 27598996
[TBL] [Abstract][Full Text] [Related]
19. microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer.
Kim S; Lee E; Jung J; Lee JW; Kim HJ; Kim J; Yoo HJ; Lee HJ; Chae SY; Jeon SM; Son BH; Gong G; Sharan SK; Chang S
Oncogene; 2018 May; 37(22):2982-2991. PubMed ID: 29527004
[TBL] [Abstract][Full Text] [Related]
20. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.
Li H; Li X; Ge X; Jia L; Zhang Z; Fang R; Yang J; Liu J; Peng S; Zhou M; Xiang J; Zeng Z; Zhou W; Xiong W; Xiao G; Fang L; Li GY; Li Z
Oncotarget; 2016 Aug; 7(34):54838-54851. PubMed ID: 27458165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]